|
|
|
||||
| Home Help Feedback Subscriptions Archive Search | |||||
The fully linked HTML version of this article has now been published.
The molecular complex containing CARMA proteins, BCL10 and TRAF6 has been identified recently as a key component in the signal transduction pathways that regulate activation of the nuclear factor
JCS ePress
online publication date 18 Mar 2008
doi: 10.1242/jcs.021105
This Article ![]()
![]()
Full Text (PDF)
![]()
All Versions of this Article:
jcs.021105v1
121/8/1165
most recent![]()
Alert me when this article is cited
![]()
Alert me if a correction is posted
![]()
Services ![]()
![]()
Email this article to a friend
![]()
Similar articles in this journal
![]()
Similar articles in PubMed
![]()
Alert me to new issues of the journal
![]()
Download to citation manager
![]()
![]()
Google Scholar ![]()
![]()
Articles by Stilo, R.
![]()
Articles by Vito, P.
![]()
PubMed ![]()
![]()
PubMed Citation
![]()
Articles by Stilo, R.
![]()
Articles by Vito, P.
Research Article
A20 is a negative regulator of BCL10- and CARMA3-mediated activation of NF-
B
* Author for correspondence (e-mail: vito{at}unisannio.it)
B (NF-
B) transcription factor. Here, we report that the inducible protein A20 negatively regulates these signaling cascades by means of its deubiquitylation activity. We show that A20 perturbs assembly of the complex containing CARMA3, BCL10 and IKK
/NEMO, thereby suppressing activation of NF-
B. Together, our results further define the molecular mechanisms that control activation of NF-
B and reveal a function for A20 in the regulation of CARMA and BCL10 activity in lymphoid and non-lymphoid cells.
© The Company of Biologists Ltd 2008